LGVN
Biotechnology · Healthcare
CFO
2023-07-31–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Longeveron Inc. publishes a filing, an earnings call transcript or a press release.
Get LGVN alertsLisa Locklear is recorded as CFO at Longeveron Inc. (LGVN) since July 31, 2023. Longeveron Inc. reported in an 8-K filed June 5, 2026 that Lisa Locklear resigned as Chief Financial Officer, effective July 10, 2026. Longeveron Inc. reported in an 8-K filed July 20, 2023 that Lisa Locklear was appointed Executive Vice President and Chief Financial Officer, effective July 31, 2023. The proxy statement of Longeveron Inc. reports total compensation of $862,087 for Lisa Locklear in fiscal 2025, including a base salary of $431,693. Disclosed compensation is on record for 3 fiscal years. Lisa Locklear has spoken on 11 earnings calls across 1 company, most recently for Longeveron Inc. on May 13, 2026. Longeveron Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Longeveron Inc. includes J. Nathaniel Powell (CEO), Stephen H. Willard (CEO), Stephen Willard (CEO) and 7 others.
“On June 1, 2026, Ms. Lisa Locklear informed management of Longeveron Inc. (the “Company”) of her decision to step down as Chief Financial Officer, to become effective July 10, 2026.”
“On July 20, 2023 Longeveron Inc. ("Longeveron" or the "Company") announced the appointment of Lisa Locklear to the Longeveron executive leadership team in the role of Executive Vice President and Chief Financial Officer ("CFO"), principal financial officer and principal accounting officer, effective July 31, 2023 (the "Effective Date").”
“This afternoon, we issued a press release and filed our quarterly report on Form 10-Q, both of which present our financial results in detail, so I will touch on some highlights.”
“This afternoon, we issued a press release and filed our annual report on Form 10-K, both of which present our financial results in detail, so I will touch on some highlights.”
“This afternoon, we issued a press release and filed our quarterly report on Form 10-Q, both of which present our financial results in detail, so I will touch on some highlights.”
“This afternoon, we issued a press release and filed our quarterly report on Form 10-Q, both of which present our financial results in detail, so I will touch on some highlights.”
“This afternoon, we issued a press release and filed our Annual Report on Form 10-K, both of which present our financial results in detail, so I will touch on some highlights.”
2023-07-31–present
Start not stated–2026-07-10
LGVN
Biotechnology · Healthcare
CFO
2023-07-31–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Longeveron Inc. (LGVN) | Chief Financial Officer and Treasurer | $431,693 | $862,087 |
| 2024 | Longeveron Inc. (LGVN) | Chief Financial Officer, Treasurer | $430,923 | $1,123,251 |
| 2023 | Longeveron Inc. (LGVN) | Chief Financial Officer, Treasurer | $161,539 | $380,779 |